Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure

Stopped early

Conditions studied: Thrombocytopenia

In brief

Phase 4 observational cohort study to characterize the treatment patterns and effects of avatrombopag use in patients with thrombocytopenia associated with chronic liver disease who are either undergoing, or have already undergone, a procedure.

Key facts

Study ID

NCT03554759

Run by

Sobi, Inc.

People needed

50

Starts

2018-07-02

Expected to finish

2019-01-31

Last updated by the study team

2024-10-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has thrombocytopenia associated with chronic liver disease and is planned for or underwent treatment with avatrombopag prior to a procedure
• Patient provides written informed consent
• Minimum Data for Retrospective Enrollment
• Platelet count from approximately 7 days prior to starting avatrombopag
• Platelet count on Procedure Day

Where it is running

• Dova Site — Chandler, Arizona, United States
• Dova Site — Lancaster, California, United States
• Dova Study Site — Los Angeles, California, United States
• Dova Site — Palm Springs, California, United States
• Dova Study Site — Pasadena, California, United States
• Dova Study Site — San Clemente, California, United States
• Dova Study Site — San Diego, California, United States
• Dova Study Site — San Diego, California, United States
• Dova Study Site — Aurora, Colorado, United States
• Dova Study Site — Englewood, Colorado, United States
• Dova Study Site — Gainesville, Florida, United States
• Dova Study Site — Miami, Florida, United States
• Dova Study Site — Atlanta, Georgia, United States
• Dova Study Site — Topeka, Kansas, United States
• Dova Study Site — Louisville, Kentucky, United States
• Dova Study Site — Baltimore, Maryland, United States
• Dova Study Site — Boston, Massachusetts, United States
• Dova Study Site — Burlington, Massachusetts, United States
• Dova Study Site — Worcester, Massachusetts, United States
• Dova Study Site — Ann Arbor, Michigan, United States
• Dova Study Site — Detroit, Michigan, United States
• Dova Site — Jackson, Mississippi, United States
• Dova Study Site — New Brunswick, New Jersey, United States
• Dova Study Site — Manhasset, New York, United States
• Dova Study Site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.